Centre extends tenure of DCGI Dr V G Somani by another three months

The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been again extended by another three months, according to an order issued by the Union Health Ministry

V G SOMANI / Drug Controller General of India, dcgi
V G Somani, Drug Controller General of India
Press Trust of India New Delhi
1 min read Last Updated : Nov 16 2022 | 7:46 PM IST

The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been again extended by another three months, according to an order issued by the Union Health Ministry.

The extension will come into effect from Tuesday, the order said.

He was earlier given an extension in August this year.

"In continuation to office order dated 16.08.2022, the competent authority has concurred approval for Dr V G Somani, to continue to hold the charge of the post of Drugs Controller of (India) for a further period of three months w.e.f. 16.11.2022 or until further order, whichever is earlier," it said.

Dr Somani was appointed the DCGI for a term of three years on August 14, 2019.

The DCGI heads the Central Drugs Standard Control Organisation (CDSCO), which is responsible for ensuring quality drugs supply across the country.It also has authority to give approval to new drugs and regulate clinical trials.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CentreDrug Controller General of Indiaindian government

First Published: Nov 16 2022 | 7:46 PM IST

Next Story